Interarch Building Products shares listed on the BSE and NSE with over 44% premium against the issue price of Rs 900. The company's market valuation stood at Rs 2,031.80 crore.

Interarch Building Products IPO received a massive 93.46 times subscription, with strong demand from QIBs, Non-Institutional Investors, and Retail Investors. The IPO raised Rs 600 crore, with...

Interarch Building Products IPO received 10.83 times subscription on day 2, with strong demand from non-institutional investors and retail investors. The IPO, priced at Rs 850-900 per share, is set...

Interarch Building Products IPO was fully subscribed on Day 1, receiving 3.19 times subscription. The offer for sale will conclude on August 21. Learn more.

Interarch Building Products IPO to open on Aug 19, raising Rs 600 crore. The price band is set at Rs 850-900 per share. The IPO comprises a fresh issue and offer-for-sale.

Transformers and Rectifiers (India) Ltd secures new orders worth Rs 252 crore, including transformers and reactors, to be executed by the next financial year.

Nokia to invest in its Chennai R&D facility, making it the largest for fixed network business. The expansion highlights Nokia's commitment to innovation and bridging the digital divide.

Zydus Lifesciences receives USFDA approval to market Scopolamine transdermal system for nausea and vomiting prevention. This is the fifth ANDA approval for Zydus in the transdermal portfolio.

The Indian rupee strengthened against the US dollar on Friday, closing at 83.86, supported by strong domestic equities and weak US dollar. Foreign fund inflows also boosted the rupee, while rising...

The Comptroller and Auditor General of India (CAG) has signed an MoU with the General Court of Audit of Saudi Arabia to enhance cooperation in public sector auditing, including joint training...

Transformers and Rectifiers (India) Ltd secures new orders worth Rs 252 crore, including transformers and reactors, to be executed by the next financial year.

Nokia to invest in its Chennai R&D facility, making it the largest for fixed network business. The expansion highlights Nokia's commitment to innovation and bridging the digital divide.

Zydus Lifesciences receives USFDA approval to market Scopolamine transdermal system for nausea and vomiting prevention. This is the fifth ANDA approval for Zydus in the transdermal portfolio.

Indian equity benchmarks Sensex and Nifty surged to fresh all-time highs on Friday, driven by positive global markets and foreign fund inflows. Key index majors like Bharti Airtel, ICICI Bank, and...

The Indian rupee strengthened against the US dollar on Friday, closing at 83.86, supported by strong domestic equities and weak US dollar. Foreign fund inflows also boosted the rupee, while rising...